WallStSmart

Salesforce.com Inc (CRM)vsResearch Solutions Inc (RSSS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Salesforce.com Inc generates 87909% more annual revenue ($42.83B vs $48.66M). CRM leads profitability with a 18.7% profit margin vs 9.3%. CRM appears more attractively valued with a PEG of 1.02. CRM earns a higher WallStSmart Score of 71/100 (B).

CRM

Strong Buy

71

out of 100

Grade: B

Growth: 7.3Profit: 7.5Value: 7.3Quality: 4.5
Piotroski: 5/9Altman Z: 1.50

RSSS

Buy

54

out of 100

Grade: C-

Growth: 6.7Profit: 6.5Value: 5.3Quality: 3.3
Piotroski: 3/9Altman Z: 0.58
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CRMUndervalued (+74.7%)

Margin of Safety

+74.7%

Fair Value

$722.63

Current Price

$185.66

$536.97 discount

UndervaluedFair: $722.63Overvalued
RSSSOvervalued (-6.4%)

Margin of Safety

-6.4%

Fair Value

$2.36

Current Price

$2.25

$0.11 premium

UndervaluedFair: $2.36Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRM5 strengths · Avg: 8.8/10
EPS GrowthGrowth
52.2%10/10

Earnings expanding 52.2% YoY

Market CapQuality
$164.49B9/10

Large-cap with strong market position

Return on EquityProfitability
23.4%9/10

Every $100 of equity generates 23 in profit

Operating MarginProfitability
21.8%8/10

Strong operational efficiency at 21.8%

Free Cash FlowQuality
$6.56B8/10

Generating 6.6B in free cash flow

RSSS3 strengths · Avg: 9.0/10
EPS GrowthGrowth
285.4%10/10

Earnings expanding 285.4% YoY

Return on EquityProfitability
23.7%9/10

Every $100 of equity generates 24 in profit

P/E RatioValuation
15.3x8/10

Attractively priced relative to earnings

Areas to Watch

CRM2 concerns · Avg: 3.5/10
Altman Z-ScoreHealth
1.504/10

Distress zone — elevated risk

Debt/EquityHealth
1.223/10

Elevated debt levels

RSSS4 concerns · Avg: 3.0/10
PEG RatioValuation
1.684/10

Expensive relative to growth rate

Market CapQuality
$76.93M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-4.3%2/10

Revenue declined 4.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : CRM

The strongest argument for CRM centers on EPS Growth, Market Cap, Return on Equity. Profitability is solid with margins at 18.7% and operating margin at 21.8%. Revenue growth of 13.3% demonstrates continued momentum.

Bull Case : RSSS

The strongest argument for RSSS centers on EPS Growth, Return on Equity, P/E Ratio.

Bear Case : CRM

The primary concerns for CRM are Altman Z-Score, Debt/Equity.

Bear Case : RSSS

The primary concerns for RSSS are PEG Ratio, Market Cap, Piotroski F-Score.

Key Dynamics to Monitor

CRM profiles as a mature stock while RSSS is a value play — different risk/reward profiles.

CRM carries more volatility with a beta of 1.14 — expect wider price swings.

CRM is growing revenue faster at 13.3% — sustainability is the question.

CRM generates stronger free cash flow (6.6B), providing more financial flexibility.

Bottom Line

CRM scores higher overall (71/100 vs 54/100), backed by strong 18.7% margins and 13.3% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Salesforce.com Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Salesforce.com, Inc. is an American cloud-based software company headquartered in San Francisco, California. It provides customer relationship management (CRM) service and also provides a complementary suite of enterprise applications focused on customer service, marketing automation, analytics, and application development.

Visit Website →

Research Solutions Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Research Solutions, Inc., provides annual licenses that allow customers to access and use functions of the cloud-based software-as-a-service research intelligence platform. The company is headquartered in Henderson, Nevada.

Want to dig deeper into these stocks?